Adverse immune reactions and the pathogenesis of Ostertagia ostertagi infections in calves.
The possible development of type-1 hypersensitivity reactions in the abomasal mucosa caused by soluble L3 products of Ostertagia ostertagi was studied in 4-month-old calves sensitized by repeated exposure to L3 over a 50-day period followed by anthelmintic treatment. Four groups each of 4 calves were used. Group 1 served as nonsensitized controls and group 2 as sensitized controls, group 3 was challenge exposed at 2-week intervals beginning at week 10 with a soluble L3 product (OAG), and group 4 was challenge exposed at 2-week intervals with an oral dose of L3, followed by anthelmintic treatment 3 days later. All calves infected with L3 became sensitized, as indicated by a positive reaction to an intradermal skin test. However, a passive cutaneous anaphylaxis was only partly effective in indicating the presence of homocytotropic antibody in the infected calves. Sensitized calves had significantly (P less than 0.05) higher eosinophil counts and plasma pepsinogen values for the entire 14 weeks than uninfected controls. Globule leukocyte and mast cell counts from the abomasal mucosa were also significantly (P less than 0.05) higher. Studies for possible immunomodulation revealed that lymphocyte counts decreased between every 2-week challenge-exposure period for groups-3 and -4 calves. A transient depression of blood lymphocyte (BL) responses to phytohemagglutinin (PHA), a T-cell mitogen, was observed over the first 8 weeks in the infected calves. Increases in BL responses to OAG were also observed. Differences were not observed in BL responses to pokeweed mitogen, a T- and B-cell mitogen. Blood lymphocyte responses to PHA in group-3 calves were low following the initial challenge exposure with OAG.(ABSTRACT TRUNCATED AT 250 WORDS)
Wiggin
C J
CJ
Department of Animal and Veterinary Sciences, University of Maine, Orono 04469.
Gibbs
H C
HC
D000018:Abomasum / Q000166:cytology; D000818:Animals; D000947:Antigens, Helminth / Q000276:immunology*; D002417:Cattle; D002418:Cattle Diseases / Q000209:etiology / Q000276:immunology*; D005243:Feces / Q000469:parasitology; D005273:Fenbendazole / Q000627:therapeutic use; D006967:Hypersensitivity / Q000209:etiology / Q000469:parasitology / Q000662:veterinary*; D007958:Leukocyte Count; D008213:Lymphocyte Activation; D008297:Male; D010028:Ostertagia / Q000276:immunology / Q000472:pathogenicity; D010029:Ostertagiasis / Q000209:etiology / Q000276:immunology / Q000662:veterinary*; D010270:Parasite Egg Count; D010435:Pepsinogens / Q000097:blood; D011897:Random Allocation; D013997:Time Factors; D014252:Trichostrongyloidiasis / Q000662:veterinary*
D000947:Antigens, Helminth; D010435:Pepsinogens; D005273:Fenbendazole